AMGN

Amgen

D
AMGN
USD
-4.27
(-1.3383%)
Market Closed
132,651.00
Volume
19.27
EPS
2.78
Div Yield
44.970
P/E
168,864,276,694.68
Market Cap
Today
-1.3383%
1 Week
0.540%
1 Month
18.453%
6 Months
17.005%
12 Months
38.138%
Year To Date
9.272%
All Time
0%
News

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
GILD
GILD
0.86
(1.2834%)
USD
B
BIIB
-5.45
(-2.3148%)
USD
REGN
REGN
-10.43
(-1.0663%)
USD
BMY
BMY
-0.44
(-0.9874%)
USD
LLY
LLY
-15.73
(-1.9975%)
USD
PFE
PFE
0.115
(0.3991%)
USD
MRK
MRK
-0.84
(-0.6376%)
USD
JNJ
JNJ
1.59
(1.0412%)
USD

Title:
Amgen

Sector:
Healthcare
Industry:
Drug Manufacturers - General
Amgen Inc. is an American global biopharmaceutical company that engages in the development, manufacture and marketing of human therapeutics. It is headquartered in Thousand Oaks, California. The company has deep interests in molecular biology and biochemistry, which underpin its goal to provide human care based on recombinant DNA technology. Some of the company’s best-performing products include Neulasta and Enbrel. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980.
Do you need help or have a question?
Contact Us